moksha8 Pharmaceuticals Competitors and Similar CompaniesClear all

moksha8 Pharmaceuticals's competitors and similar companies include Supernus Pharmaceuticals, Calliditas Therapeutics, Autifony Therapeutics and Ethismos Research.

	moksha8 Pharmaceuticals Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders.	Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.	Calliditas Therapeutics Calliditas Therapeutics is a biopharmaceutical company focused on identifying, developing, and commercializing treatments in orphan indications.	Autifony Therapeutics Autifony Therapeutics is a biotechnology company that develops new drugs to treat serious disorders of the central nervous system.	Ethismos Research Ethismos Research is a drug discovery company developing therapies to address addiction and depression.
Founding Date	Founding Date 2006	Founding Date 2005	Founding Date 2004	Founding Date 2011	Founding Date N/A
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech mental health pharma therapy	Tags Healthcare biotech drug development mental health pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech drug development mental health pharma therapy	Tags Healthcare drug development mental health pharma therapy
Locations	Locations Berwyn, US HQ Ciudad De México, MX	Locations Rockville, US HQ	Locations Stockholm, SE HQ Archamps, FR Stockholm, SE Stockholm, SE Plan Les Ouates, CH Hoboken, US New York, US	Locations Stevenage, GB HQ Padova, IT	Locations Cambridge, US HQ
Employees	Employees 370	Employees 6527% increase	Employees 2221% increase	Employees 3017% decrease	Employees 18
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.9 b	Valuation ($) 1.1 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $719m (FY, 2025)	Revenue (est.) kr1.2b (FY, 2023)	Revenue (est.) £22.8m (FY, 2018)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $74.6m (FY, 2025)	Cost of goods kr60.5m (FY, 2023)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $644.4m (FY, 2025)	Gross profit kr1.2b (FY, 2023)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($38.6m) (FY, 2025)	Net income (kr466.2m) (FY, 2023)	Net income £16.2m (FY, 2018)	Net income N/A
Funding
Latest funding round	Latest funding round $ 125m (over 13 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 12.3m (almost 11 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 224.1m	Total funding raised $ 69.5m	Total funding raised $ 33.2m	Total funding raised $ 24.2m	Total funding raised N/A

For sources of this data, please see the company profile

View Company Profiles

Supernus Pharmaceuticals

Rockville, US

Employees

652↑ 7% increase

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.

View company

Calliditas Therapeutics

Stockholm, SE

Employees

222↑ 1% increase

Calliditas Therapeutics is a biopharmaceutical company focused on identifying, developing, and commercializing treatments in orphan indications.

View company

Autifony Therapeutics

Stevenage, GB

Employees

30↓ 17% decrease

Autifony Therapeutics is a biotechnology company that develops new drugs to treat serious disorders of the central nervous system.